
About Lenticular Research Group
Lenticular Research Group is a Healthcare company based in Naperville (United States) founded in 2007 by George J McArdle. Developer of laser device for treating the cause of presbyopia. Lenticular Research Group has raised $330 thousand across 1 funding round. Its chief executive, as recorded, is George J McArdle. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Lenticular Research Group, LLC. Its competitors include Clerio Vision and IntraLase; 2 of its 2 listed competitors have raised funding.
Company details
Lenticular Research Group has developed a laser device for treating presbyopia. The laser device is used for targeted therapy to the germinative zone of the crystalline lens to inhibit inhibits epithelial cell reproduction to arrest the progression of presbyopia in the early stage.
- Headquarters Naperville, United States
- Founders George J McArdle
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website lenticularresearchgroup.com
- Legal Name Lenticular Research Group, Llc
- Total Equity Funding$330K (USD)
in 1 rounds
- Latest Funding Round$330K (USD), Seed
Aug 2015
Funding Insights of Lenticular Research Group
Lenticular Research Group has successfully raised a total of $330K through 1 strategic funding round. The most recent funding activity was a Seed round of $330 thousand completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $330,000
- Total Rounds 1
- Last Round Seed β $330,000
- First Round $330,000
(Aug 2015)
All 1 funding rounds of Lenticular Research Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2015 | $330,000 | Seed | β | β | β |
People of Lenticular Research Group
9 people are tracked at Lenticular Research Group (1 in leadership, 7 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
George J McArdle | Founder & CEO | Leadership |
Richard L. Lindstrom | Advisor | Board & advisors |
Roger Steinert | Advisor | Board & advisors |
Daniel S. Durrie | Advisor | Board & advisors |
Vance Thompson | Advisor | Board & advisors |
William B. Trattler | Advisor | Board & advisors |
Louis Probst | Advisor | Board & advisors |
Steve Schallhorn | Advisor | Board & advisors |
Rebecca Zoltoski | Research Team Lead | Team |
Complete people profiles for Lenticular Research Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lenticular Research Group
2 dated milestones of Lenticular Research Group across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Lenticular Research Group is founded.
- Funding First funding round of $330K.
Competitors of Lenticular Research Group
Lenticular Research Group has 2 listed competitors in our database, 2 of them funded. They include Clerio Vision and IntraLase.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cleriovision.com | 2014 | Rochester, United States | $28.95M | 90 | Laser induced change in refractive index | |
| intralase.com | 1997 | Irvine, United States | $29.5M | Femtosecond laser technology is developed for eye surgery procedures. |
Detailed competitors of Lenticular Research Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as Lenticular Research Group (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 24.69 B | 25,941 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lenticular Research Group
Lenticular Research Group was founded in 2007 and raised its 1st funding round 8 years after it was founded.
Lenticular Research Group is headquartered in Naperville, United States. It is registered at Naperville, Illinois, United States.
George J McArdle is the CEO of Lenticular Research Group, as recorded in our data. They have also founded this company.
Lenticular Research Group is a funded company, having raised a total of $330K across 1 funding round to date. The company's 1st funding round was a Seed of $330K, raised on Aug 2015.
Lenticular Research Group has developed a laser device for treating presbyopia. The laser device is used for targeted therapy to the germinative zone of the crystalline lens to inhibit inhibits epithelial cell reproduction to arrest the progression of presbyopia in the early stage.
Lenticular Research Group's top competitors include Clerio Vision and IntraLase.
Lenticular Research Group operates through Lenticular Research Group, Llc.